224 related articles for article (PubMed ID: 31562527)
21. Prediction of pathology in primary progressive language and speech disorders.
Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
[TBL] [Abstract][Full Text] [Related]
22. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
[TBL] [Abstract][Full Text] [Related]
23. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
[TBL] [Abstract][Full Text] [Related]
24.
Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
[TBL] [Abstract][Full Text] [Related]
25. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
26. Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss.
Carlos AF; Koga S; Graff-Radford NR; Baker MC; Rademakers R; Ross OA; Dickson DW; Josephs KA
Neuropathology; 2024 Apr; 44(2):115-125. PubMed ID: 37525358
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
[TBL] [Abstract][Full Text] [Related]
29. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
[TBL] [Abstract][Full Text] [Related]
30. Amyloid in dementia associated with familial FTLD: not an innocent bystander.
Naasan G; Rabinovici GD; Ghosh P; Elofson JD; Miller BL; Coppola G; Karydas A; Fong J; Perry D; Lee SE; Yokoyama JS; Seeley WW; Kramer JH; Weiner MW; Schuff N; Jagust WJ; Grinberg LT; Pribadi M; Yang Z; Sears R; Klein E; Wojta K; Rosen HJ
Neurocase; 2016; 22(1):76-83. PubMed ID: 26040468
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.
Sieben A; Van Langenhove T; Vermeiren Y; Gossye H; Praet M; Vanhauwaert D; Cousaert C; Engelborghs S; Raedt R; Boon P; Santens P; De Deyn PP; Bracke KR; De Meulemeester K; Van Broeckhoven C; Martin JJ; Bjerke M
J Neuropathol Exp Neurol; 2021 Mar; 80(4):313-324. PubMed ID: 33638350
[TBL] [Abstract][Full Text] [Related]
32. The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals.
Wennberg AM; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Machulda MM; Petrucelli L; Mielke MM; Jack CR; Knopman DS; Parisi JE; Petersen RC; Dickson DW; Josephs KA
Neurobiol Aging; 2019 May; 77():26-36. PubMed ID: 30776649
[TBL] [Abstract][Full Text] [Related]
33. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
[TBL] [Abstract][Full Text] [Related]
34. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
[TBL] [Abstract][Full Text] [Related]
35. Regional and hemispheric susceptibility of the temporal lobe to FTLD-TDP type C pathology.
Borghesani V; Battistella G; Mandelli ML; Welch A; Weis E; Younes K; Neuhaus J; Grinberg LT; Seeley WM; Spina S; Miller B; Miller Z; Gorno-Tempini ML
Neuroimage Clin; 2020; 28():102369. PubMed ID: 32798912
[TBL] [Abstract][Full Text] [Related]
36. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
Rohrer JD; Lashley T; Schott JM; Warren JE; Mead S; Isaacs AM; Beck J; Hardy J; de Silva R; Warrington E; Troakes C; Al-Sarraj S; King A; Borroni B; Clarkson MJ; Ourselin S; Holton JL; Fox NC; Revesz T; Rossor MN; Warren JD
Brain; 2011 Sep; 134(Pt 9):2565-81. PubMed ID: 21908872
[TBL] [Abstract][Full Text] [Related]
37. In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology.
Bocchetta M; Iglesias Espinosa MDM; Lashley T; Warren JD; Rohrer JD
Alzheimers Res Ther; 2020 Mar; 12(1):34. PubMed ID: 32220237
[TBL] [Abstract][Full Text] [Related]
38. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Perkerson RB; Matchett BJ; Jack CR; Knopman DS; Petersen RC; Parisi JE; Petrucelli L; Baker M; Rademakers R; Whitwell JL; Dickson DW
Acta Neuropathol; 2019 Feb; 137(2):227-238. PubMed ID: 30604226
[TBL] [Abstract][Full Text] [Related]
39. Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration.
Long Z; Irish M; Hodges JR; Halliday G; Piguet O; Burrell JR
Neurobiol Aging; 2021 Nov; 107():11-20. PubMed ID: 34371283
[TBL] [Abstract][Full Text] [Related]
40. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study.
Whitwell JL; Przybelski SA; Weigand SD; Ivnik RJ; Vemuri P; Gunter JL; Senjem ML; Shiung MM; Boeve BF; Knopman DS; Parisi JE; Dickson DW; Petersen RC; Jack CR; Josephs KA
Brain; 2009 Nov; 132(Pt 11):2932-46. PubMed ID: 19762452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
